Introduction to An Overview on Anti-epileptic Drugs,
Introduction to Epilepsy, Types of Seizures, Classification, Mechanism of Action, Pharmacokinetics, Uses, Adverse Effects, Contraindications, New Drugs
Presented by
A. Harsha Vardan Naidu
Department of Pharmacology
Parkinsonism is a progressive neurological disorder characterized by bradykinesia, muscular rigidity, resting tremor, and impaired balance. It can be caused by idiopathic Parkinson's disease, vascular issues, certain drugs that block dopamine, or dementia with Lewy bodies. Treatment aims to increase dopamine in the brain and involves levodopa, dopamine agonists, MAO inhibitors, COMT inhibitors, amantadine, and anticholinergic drugs.
This document summarizes various classes of analgesic drugs including narcotics/opioids, non-narcotics, and specific drugs within each class. It describes the mechanism of action, uses, and side effects of common opioid analgesics like morphine, methadone, fentanyl, and non-opioid analgesics like acetaminophen. It also discusses opioid receptor types and how different drugs can act as agonists, antagonists, or mixed agonist-antagonists at these receptors.
This document summarizes parasympatholytic drugs, also known as anticholinergic or antimuscarinic drugs. It discusses the pharmacological properties and uses of atropine and scopolamine, which are belladonna alkaloids that act as competitive inhibitors at muscarinic receptors in the parasympathetic nervous system. It also describes newer anticholinergic drugs that have more selective actions, such as ipratropium bromide and tiotropium bromide for bronchodilation in respiratory disorders, and oxybutynin for urinary incontinence.
Parasympathomimetic or cholinergic drugs act on cholinergic receptors in the parasympathetic nervous system to produce effects similar to parasympathetic stimulation. They have two types of activities: muscarinic and nicotinic. Examples include direct-acting drugs like acetylcholine and indirect-acting anticholinesterases. Anticholinesterases inhibit the enzyme cholinesterase, leading to accumulation of acetylcholine at receptor sites. They are used to treat conditions like glaucoma, myasthenia gravis, Alzheimer's disease, and organophosphate poisoning.
This document summarizes cholinergic transmission and the actions of acetylcholine (ACh) as a neurotransmitter. It discusses ACh synthesis, storage, release and metabolism by acetylcholinesterase. It describes the two classes of cholinergic receptors - muscarinic and nicotinic receptors. The document outlines the pharmacological actions and uses of parasympathomimetic drugs like pilocarpine, muscarine, and anticholinesterases. It also discusses the treatment of myasthenia gravis and organophosphate poisoning using anticholinesterases.
Introduction to Opioid analgesis, Terms, History, Classification, Morphine, Opioid receptors, Mechanism of action, Pharmacological actions of morphine, Pharmacokinetics, Adverse effects, Contraindications, Therapeutic uses
Presented by
B . Kranthi Kumar
Department of Pharmacology
Parkinsonism is a progressive neurological disorder characterized by bradykinesia, muscular rigidity, resting tremor, and impaired balance. It can be caused by idiopathic Parkinson's disease, vascular issues, certain drugs that block dopamine, or dementia with Lewy bodies. Treatment aims to increase dopamine in the brain and involves levodopa, dopamine agonists, MAO inhibitors, COMT inhibitors, amantadine, and anticholinergic drugs.
This document summarizes various classes of analgesic drugs including narcotics/opioids, non-narcotics, and specific drugs within each class. It describes the mechanism of action, uses, and side effects of common opioid analgesics like morphine, methadone, fentanyl, and non-opioid analgesics like acetaminophen. It also discusses opioid receptor types and how different drugs can act as agonists, antagonists, or mixed agonist-antagonists at these receptors.
This document summarizes parasympatholytic drugs, also known as anticholinergic or antimuscarinic drugs. It discusses the pharmacological properties and uses of atropine and scopolamine, which are belladonna alkaloids that act as competitive inhibitors at muscarinic receptors in the parasympathetic nervous system. It also describes newer anticholinergic drugs that have more selective actions, such as ipratropium bromide and tiotropium bromide for bronchodilation in respiratory disorders, and oxybutynin for urinary incontinence.
Parasympathomimetic or cholinergic drugs act on cholinergic receptors in the parasympathetic nervous system to produce effects similar to parasympathetic stimulation. They have two types of activities: muscarinic and nicotinic. Examples include direct-acting drugs like acetylcholine and indirect-acting anticholinesterases. Anticholinesterases inhibit the enzyme cholinesterase, leading to accumulation of acetylcholine at receptor sites. They are used to treat conditions like glaucoma, myasthenia gravis, Alzheimer's disease, and organophosphate poisoning.
This document summarizes cholinergic transmission and the actions of acetylcholine (ACh) as a neurotransmitter. It discusses ACh synthesis, storage, release and metabolism by acetylcholinesterase. It describes the two classes of cholinergic receptors - muscarinic and nicotinic receptors. The document outlines the pharmacological actions and uses of parasympathomimetic drugs like pilocarpine, muscarine, and anticholinesterases. It also discusses the treatment of myasthenia gravis and organophosphate poisoning using anticholinesterases.
Introduction to Opioid analgesis, Terms, History, Classification, Morphine, Opioid receptors, Mechanism of action, Pharmacological actions of morphine, Pharmacokinetics, Adverse effects, Contraindications, Therapeutic uses
Presented by
B . Kranthi Kumar
Department of Pharmacology
Epilepsy is characterized by recurrent seizures and is treated using anticonvulsant drugs like phenytoin, carbamazepine, valproic acid, phenobarbital, and benzodiazepines. Phenytoin works by blocking sodium channels in neurons to inhibit neuronal firing and seizures. Carbamazepine has a similar mechanism of action and indication as phenytoin. Valproic acid enhances GABA levels to reduce seizures. Choice of anticonvulsant depends on seizure type, with carbamazepine, phenytoin, and valproic acid used for partial seizures and valproic acid and diazepam used for absence seizures.
cholingeric and Anticholinesterase drug in detail .this ppt contains introduction ,mechanism of action ,pharmacological action ,uses and adverse effect of the drug
Ganglionic stimulants like nicotine can activate nicotinic receptors in autonomic ganglia, resulting in the stimulation of both sympathetic and parasympathetic responses. Although they have limited medical use, nicotine has been used experimentally to help identify nerve fibers. Ganglionic blockers are competitive antagonists at nicotinic receptors that reduce autonomic tone, and were once used to treat hypertension and peptic ulcers but caused intolerable side effects. Trimethaphan is a short-acting ganglionic blocker occasionally used for controlled hypotension. Mecamylamine has been studied for smoking cessation by blocking nicotine's rewarding effects but also causes constipation. Currently there is no significant
This document summarizes skeletal muscle relaxants. It describes both peripherally-acting and centrally-acting muscle relaxants. Peripherally-acting muscle relaxants include neuromuscular blocking agents like nondepolarizing (competitive) blockers and depolarizing blockers, which act at the neuromuscular junction. Centrally-acting muscle relaxants like baclofen, tizanidine and mephenesin derivatives act in the central nervous system to decrease muscle tone. The document discusses the mechanisms, uses and side effects of various muscle relaxant drugs.
This document summarizes different types of anticonvulsants used to treat epilepsy and seizure disorders. It discusses their mechanisms of action, classifications, and structure-activity relationships. The main classes covered are barbiturates, hydantoins, oxazolidinediones, succinimides, ureas, benzodiazepines, and some miscellaneous anticonvulsants like primidone, valproic acid, gabapentin, and felbamate. Each class is explained in terms of prototypical drugs, their structures, metabolic pathways, and indications for use in treating seizures.
Anticonvulsants are medications used to treat seizures and epilepsy. They work by enhancing the inhibitory neurotransmitter GABA, inhibiting sodium or calcium channels, or other mechanisms. Common anticonvulsants discussed include carbamazepine, phenytoin, lamotrigine, ethosuximide, phenobarbital, valproate, and benzodiazepines like diazepam. Each drug has specific indications, mechanisms of action, dosing regimens, side effects, and contraindications.
Myasthenia gravis is an autoimmune disorder that causes muscle weakness. It occurs when antibodies block or destroy receptors at the neuromuscular junction, preventing signal transmission from nerves to muscles. Common symptoms include drooping eyelids, double vision, difficulty swallowing and breathing. While there is no cure, treatment aims to control symptoms through medications like cholinesterase inhibitors or immunosuppressants, plasmapheresis, intravenous immunoglobulin or thymectomy. Proper nutrition, rest and exercise are also important for management of the condition.
General anesthesia involves using drugs to induce a reversible loss of consciousness during surgery, while local anesthesia inhibits nerve impulses in a restricted area to reduce pain from procedures. The main types of general anesthetics are inhalational gases like nitrous oxide and volatile liquids like halothane administered by an anesthesiologist, and intravenous drugs used for induction and maintenance like thiopental and propofol. Anesthesia works through various stages from analgesia to unconsciousness and involves theories of action on lipid membranes or specific membrane proteins. Choice of agent depends on properties like safety, potency, and ease of administration and recovery.
Benzodiazepines are a class of drugs that bind to GABAA receptors in the brain and enhance the effect of the neurotransmitter GABA, resulting in sedation, hypnosis, anti-anxiety, and anticonvulsant effects. They have a benzene ring fused to a seven-membered diazepine ring in their chemical structure. Common benzodiazepines include diazepam, alprazolam, lorazepam, and clonazepam. They are well absorbed orally and metabolized in the liver, with pharmacokinetic properties varying between short, intermediate, and long-acting types. Adverse effects can include fatigue, impaired
cholinergic receptors definetion and classifcation to 1-nicotinic and 2-muscarinic ...and their subtybes ..... then the sites and the mechanism ... and last the drugs effect
This document summarizes treatments for Parkinson's disease. It begins by describing the symptoms and pathogenesis of the disease. The main treatments discussed are levodopa, dopamine agonists like bromocriptine and pramipexole, MAO-B inhibitors like selegiline, and COMT inhibitors like entacapone. These work to restore the dopamine/acetylcholine balance in the basal ganglia. Levodopa is most effective initially but causes dyskinesias long term. Dopamine agonists have less motor effect but fewer dyskinesias. Combination therapy aims to control symptoms and delay adverse effects.
Hippocrates first suggested epilepsy was a brain disorder in 400 BC. It is defined as brief episodes of loss of consciousness due to abnormal brain neuron firing. Seizures can be focal or generalized. Common seizure types include generalized tonic-clonic, absence, myoclonic, complex partial, and simple partial. Antiepileptic drugs work by modifying ion conductances like sodium channels, increasing GABA effects, or blocking glutamate receptors. Common antiepileptic drugs include phenytoin, carbamazepine, valproic acid, ethosuximide, and phenobarbital. Adverse effects and drug interactions must be monitored with long-term antiepileptic treatment.
Drugs used in myasthenia gravis and galucomaAshviniGovande
This document provides information about myasthenia gravis (MG) and drugs used to treat it, as well as information about glaucoma and drugs used to treat glaucoma.
MG is an autoimmune disorder causing muscle weakness due to antibodies blocking acetylcholine receptors at the neuromuscular junction. Drugs used to treat MG include acetylcholinesterase inhibitors like pyridostigmine to increase acetylcholine levels, immunosuppressants to reduce antibody production, and thymectomy to remove the thymus gland source of antibodies.
Glaucoma involves increased fluid pressure in the eye damaging the optic nerve. The most common type is primary open-angle glaucoma. Drugs
H1-antihistamines are used to treat allergy symptoms. Within this group are two generations called the first generation and second generation antihistamines. H2-antihistamines are used to treat gastrointestinal conditions.
The H2 receptor antagonists are reversible competitive blockers of histamine at the H2 receptors, particularly those in the gastric parietal cells, where they inhibit acid secretion. They are highly selective, do not affect the H1 receptors, and are not anticholinergic agents.
The key difference between H1 and H2 receptors is that the H1 receptor couples with Gq/11 stimulating phospholipase C while the H2 receptor interacts with Gs to activate adenylyl cyclase. Histamine is an organic nitrogenous compound that involves local immune responses.
1. The document discusses the structural activity relationships of various anticonvulsant drug classes including hydantoins, barbiturates, benzodiazepines, valproic acid, and succinimides. Certain aromatic or alkyl substitutions are required for optimal activity within each class.
2. New anticonvulsant compounds currently in clinical trials are discussed, such as AWD 131-138, retigabine, rufinamide, and others. These compounds have novel mechanisms of action such as blockade of voltage-activated calcium channels or increasing potassium conductance in neurons.
3. The structural features required for anticonvulsant activity are compared between drug classes to understand how chemical modifications
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Ravish Yadav
1) Parkinson's disease is a progressive disorder causing tremors, rigidity, slow movement, and impaired balance. It results from loss of dopamine-producing neurons in the brain.
2) Common drug treatments include levodopa to replace dopamine, COMT inhibitors like carbidopa to increase levodopa's effects, MAO-B inhibitors like selegiline to prolong dopamine activity, and amantadine to stimulate dopamine release.
3) While effective initially, long term levodopa use can cause dyskinesias and fluctuations; combining it with carbidopa or selegiline can improve outcomes.
This document provides information about antiepileptic drugs. It discusses the history and classification of epilepsy. It then describes several classes of antiepileptic drugs including barbiturates, benzodiazepines, succinimides, and hydentoins. For each drug class, it summarizes the mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses for treating epilepsy. The document aims to educate about different treatment options for controlling seizures.
Dr. Viraj Shinde's document provides an overview of sympathommimetic drugs. It defines them as drugs that mimic the actions of norepinephrine or epinephrine. It discusses the sympathetic and parasympathetic nervous systems, classification of sympathommimetic drugs, examples like epinephrine, mechanisms of action, therapeutic uses, and adverse effects. Receptor types, locations, agonists, and antagonists are outlined. The document also covers neurotransmitters, their criteria and the neurotransmission process. Specific drugs discussed include dopamine, isoproterenol, dobutamine, fenoldopam, phenylephrine, clonidine, and beta-2 selective agents.
Introduction to Pharmacology of Anti-depressants
Classification, Ideal characteristics, Mechanism of action, Pharmacokinetic profile, Indications, Adverse effects, Drug interactions, Contra indications, Current trends, Conclusion
Presented by
G. Sai Swetha
Department of Pharmacology
Introduction to General Anaesthetics
Introduction General Anaesthetics, Stages of anaesthesia, Classification of General Anaesthetics, Mechanism of action of General Anaesthetics, Pharmacokinetics, Pharmacodynamics, Uses, Side effects
Presented by
I. Sai Reddemma
Department of Pharmacology
Epilepsy is characterized by recurrent seizures and is treated using anticonvulsant drugs like phenytoin, carbamazepine, valproic acid, phenobarbital, and benzodiazepines. Phenytoin works by blocking sodium channels in neurons to inhibit neuronal firing and seizures. Carbamazepine has a similar mechanism of action and indication as phenytoin. Valproic acid enhances GABA levels to reduce seizures. Choice of anticonvulsant depends on seizure type, with carbamazepine, phenytoin, and valproic acid used for partial seizures and valproic acid and diazepam used for absence seizures.
cholingeric and Anticholinesterase drug in detail .this ppt contains introduction ,mechanism of action ,pharmacological action ,uses and adverse effect of the drug
Ganglionic stimulants like nicotine can activate nicotinic receptors in autonomic ganglia, resulting in the stimulation of both sympathetic and parasympathetic responses. Although they have limited medical use, nicotine has been used experimentally to help identify nerve fibers. Ganglionic blockers are competitive antagonists at nicotinic receptors that reduce autonomic tone, and were once used to treat hypertension and peptic ulcers but caused intolerable side effects. Trimethaphan is a short-acting ganglionic blocker occasionally used for controlled hypotension. Mecamylamine has been studied for smoking cessation by blocking nicotine's rewarding effects but also causes constipation. Currently there is no significant
This document summarizes skeletal muscle relaxants. It describes both peripherally-acting and centrally-acting muscle relaxants. Peripherally-acting muscle relaxants include neuromuscular blocking agents like nondepolarizing (competitive) blockers and depolarizing blockers, which act at the neuromuscular junction. Centrally-acting muscle relaxants like baclofen, tizanidine and mephenesin derivatives act in the central nervous system to decrease muscle tone. The document discusses the mechanisms, uses and side effects of various muscle relaxant drugs.
This document summarizes different types of anticonvulsants used to treat epilepsy and seizure disorders. It discusses their mechanisms of action, classifications, and structure-activity relationships. The main classes covered are barbiturates, hydantoins, oxazolidinediones, succinimides, ureas, benzodiazepines, and some miscellaneous anticonvulsants like primidone, valproic acid, gabapentin, and felbamate. Each class is explained in terms of prototypical drugs, their structures, metabolic pathways, and indications for use in treating seizures.
Anticonvulsants are medications used to treat seizures and epilepsy. They work by enhancing the inhibitory neurotransmitter GABA, inhibiting sodium or calcium channels, or other mechanisms. Common anticonvulsants discussed include carbamazepine, phenytoin, lamotrigine, ethosuximide, phenobarbital, valproate, and benzodiazepines like diazepam. Each drug has specific indications, mechanisms of action, dosing regimens, side effects, and contraindications.
Myasthenia gravis is an autoimmune disorder that causes muscle weakness. It occurs when antibodies block or destroy receptors at the neuromuscular junction, preventing signal transmission from nerves to muscles. Common symptoms include drooping eyelids, double vision, difficulty swallowing and breathing. While there is no cure, treatment aims to control symptoms through medications like cholinesterase inhibitors or immunosuppressants, plasmapheresis, intravenous immunoglobulin or thymectomy. Proper nutrition, rest and exercise are also important for management of the condition.
General anesthesia involves using drugs to induce a reversible loss of consciousness during surgery, while local anesthesia inhibits nerve impulses in a restricted area to reduce pain from procedures. The main types of general anesthetics are inhalational gases like nitrous oxide and volatile liquids like halothane administered by an anesthesiologist, and intravenous drugs used for induction and maintenance like thiopental and propofol. Anesthesia works through various stages from analgesia to unconsciousness and involves theories of action on lipid membranes or specific membrane proteins. Choice of agent depends on properties like safety, potency, and ease of administration and recovery.
Benzodiazepines are a class of drugs that bind to GABAA receptors in the brain and enhance the effect of the neurotransmitter GABA, resulting in sedation, hypnosis, anti-anxiety, and anticonvulsant effects. They have a benzene ring fused to a seven-membered diazepine ring in their chemical structure. Common benzodiazepines include diazepam, alprazolam, lorazepam, and clonazepam. They are well absorbed orally and metabolized in the liver, with pharmacokinetic properties varying between short, intermediate, and long-acting types. Adverse effects can include fatigue, impaired
cholinergic receptors definetion and classifcation to 1-nicotinic and 2-muscarinic ...and their subtybes ..... then the sites and the mechanism ... and last the drugs effect
This document summarizes treatments for Parkinson's disease. It begins by describing the symptoms and pathogenesis of the disease. The main treatments discussed are levodopa, dopamine agonists like bromocriptine and pramipexole, MAO-B inhibitors like selegiline, and COMT inhibitors like entacapone. These work to restore the dopamine/acetylcholine balance in the basal ganglia. Levodopa is most effective initially but causes dyskinesias long term. Dopamine agonists have less motor effect but fewer dyskinesias. Combination therapy aims to control symptoms and delay adverse effects.
Hippocrates first suggested epilepsy was a brain disorder in 400 BC. It is defined as brief episodes of loss of consciousness due to abnormal brain neuron firing. Seizures can be focal or generalized. Common seizure types include generalized tonic-clonic, absence, myoclonic, complex partial, and simple partial. Antiepileptic drugs work by modifying ion conductances like sodium channels, increasing GABA effects, or blocking glutamate receptors. Common antiepileptic drugs include phenytoin, carbamazepine, valproic acid, ethosuximide, and phenobarbital. Adverse effects and drug interactions must be monitored with long-term antiepileptic treatment.
Drugs used in myasthenia gravis and galucomaAshviniGovande
This document provides information about myasthenia gravis (MG) and drugs used to treat it, as well as information about glaucoma and drugs used to treat glaucoma.
MG is an autoimmune disorder causing muscle weakness due to antibodies blocking acetylcholine receptors at the neuromuscular junction. Drugs used to treat MG include acetylcholinesterase inhibitors like pyridostigmine to increase acetylcholine levels, immunosuppressants to reduce antibody production, and thymectomy to remove the thymus gland source of antibodies.
Glaucoma involves increased fluid pressure in the eye damaging the optic nerve. The most common type is primary open-angle glaucoma. Drugs
H1-antihistamines are used to treat allergy symptoms. Within this group are two generations called the first generation and second generation antihistamines. H2-antihistamines are used to treat gastrointestinal conditions.
The H2 receptor antagonists are reversible competitive blockers of histamine at the H2 receptors, particularly those in the gastric parietal cells, where they inhibit acid secretion. They are highly selective, do not affect the H1 receptors, and are not anticholinergic agents.
The key difference between H1 and H2 receptors is that the H1 receptor couples with Gq/11 stimulating phospholipase C while the H2 receptor interacts with Gs to activate adenylyl cyclase. Histamine is an organic nitrogenous compound that involves local immune responses.
1. The document discusses the structural activity relationships of various anticonvulsant drug classes including hydantoins, barbiturates, benzodiazepines, valproic acid, and succinimides. Certain aromatic or alkyl substitutions are required for optimal activity within each class.
2. New anticonvulsant compounds currently in clinical trials are discussed, such as AWD 131-138, retigabine, rufinamide, and others. These compounds have novel mechanisms of action such as blockade of voltage-activated calcium channels or increasing potassium conductance in neurons.
3. The structural features required for anticonvulsant activity are compared between drug classes to understand how chemical modifications
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Ravish Yadav
1) Parkinson's disease is a progressive disorder causing tremors, rigidity, slow movement, and impaired balance. It results from loss of dopamine-producing neurons in the brain.
2) Common drug treatments include levodopa to replace dopamine, COMT inhibitors like carbidopa to increase levodopa's effects, MAO-B inhibitors like selegiline to prolong dopamine activity, and amantadine to stimulate dopamine release.
3) While effective initially, long term levodopa use can cause dyskinesias and fluctuations; combining it with carbidopa or selegiline can improve outcomes.
This document provides information about antiepileptic drugs. It discusses the history and classification of epilepsy. It then describes several classes of antiepileptic drugs including barbiturates, benzodiazepines, succinimides, and hydentoins. For each drug class, it summarizes the mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses for treating epilepsy. The document aims to educate about different treatment options for controlling seizures.
Dr. Viraj Shinde's document provides an overview of sympathommimetic drugs. It defines them as drugs that mimic the actions of norepinephrine or epinephrine. It discusses the sympathetic and parasympathetic nervous systems, classification of sympathommimetic drugs, examples like epinephrine, mechanisms of action, therapeutic uses, and adverse effects. Receptor types, locations, agonists, and antagonists are outlined. The document also covers neurotransmitters, their criteria and the neurotransmission process. Specific drugs discussed include dopamine, isoproterenol, dobutamine, fenoldopam, phenylephrine, clonidine, and beta-2 selective agents.
Introduction to Pharmacology of Anti-depressants
Classification, Ideal characteristics, Mechanism of action, Pharmacokinetic profile, Indications, Adverse effects, Drug interactions, Contra indications, Current trends, Conclusion
Presented by
G. Sai Swetha
Department of Pharmacology
Introduction to General Anaesthetics
Introduction General Anaesthetics, Stages of anaesthesia, Classification of General Anaesthetics, Mechanism of action of General Anaesthetics, Pharmacokinetics, Pharmacodynamics, Uses, Side effects
Presented by
I. Sai Reddemma
Department of Pharmacology
Introduction to Histamine and Antihistamine
Role of histamine, Synthesis, Storage, release of histamine
Mechanism of action of histamine
Anti histamine, Therapeutic uses, Adverse effects
Presented by
Shaik Sabeena
Department of Pharmacology
Introduction to Immunotherapeutics
Cell mediated & humoral immunity, Immunosuppressants, Immunostimulants
Presented by
G. Sai Swetha
Department of Pharmacology
Introduction to Anticoagulants
Coagulants, Local agents, Systemic agents, Anticoagulants, Heparin, Low molecular weight heparins, Heparinoids, Oral anticoagulants (Warfarin), Therapeutic uses
Presented by
N. Ramya
Department of Pharmacology
Introduction to Neuro Degenerative Diseases, Neurodegenerative diseases, Parkinson Disease, Alzhimer’s Disease, Newer Drugs
Presented by
K. THANMAYA DIVYA
Department of Pharmacology
Introduction to Physiological and pathological role of serotonin
Autocoids, Classification, synthesis ,Serotonergic receptors, Physiological actions, Pathophysiological role
Presented by
K.Firdous banu
Department of Pharmacology
In this slide contains introduction, principle, precautions, solution and assay method for vitamin B series.
Presented by: P. VENKATESH (Department of pharmaceutical analysis),
RIPER, anantapur
In this slide contains diabetics, classification, symptoms, complication, invivo and invitro screening models of anti diabetics.
Presented by: GEETHANJALI ADAPALA (Department of pharmacology).
RIPER, anantapur
This document discusses drugs used to treat heart failure. It describes how heart failure occurs when the heart cannot adequately pump blood due to problems with contraction or filling. Several classes of drugs are used to treat chronic and acute heart failure, including diuretics, ACE inhibitors, ARBs, and beta blockers. The document also examines new drug therapies currently in clinical trials that target different mechanisms like cardiac myosin activation.
Introduction to An Overview of Antipsychotic Drugs
Definition of psychosis, Causes of psychosis, Symptoms of psychosis, Classification of anti psychotic drugs, Mechanism of action, Pharmacokinetics, Adverse effects, Therapeutic uses, Contraindications, New inventions
Presented by
T. Niranjan Reddy
Department of Pharmacology
Introduction to Sedative-Hypnotics Drugs
Sleep, Introduction to Sedatives -hypnotics, Sedative-hypnotic drug classification, Pharmacology of sedative-hypnotic drugs, Overview, New inventions
Presented by
AGGIM SUMASHREE
Department of Pharmacology
Introduction to Screening Models of Hepatoprotective Drugs
Liver toxicity, Drugs causing DILI, Markers of hepatotoxicity
List of hepatoprotectives, Functions of liver
Screening models of hepatoprotective drugs
Presented by
I. Sai Reddemma
Department of Pharmacology
Introduction to Screening Models of Anti-Atherosclerosis
Atherosclerosis, Screening models, In vitro models, In vivo models
Presented by
SHAIK FIRDOUS BANU
Department of Pharmacology
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
Introduction to Genetic Variation in GPCR
G-Protein couple Receptor
Genetic variation in GPCRs
V2 Vasopressin Receptor, Thrombroxane Receptor, P2Y 12ADP Receptor, Chemokine Receptor, Biogenic amine receptors
Presented by
R. REKHA
Department of Pharmacology
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Definitions, Severity assessment, Seriousness assessment
Naranjo algorithm, Preventability assessment
By
Ms. B. Mary Vishali
Department of Pharmacology
REPRODUCTIVE TOXICITY STUDIES, Definition
Introduction, OECD guidelines for reproductive toxicity studies
Principle of the test, Description of Method, Procedure, Experimental Schedule, Data and Reporting, Results, Male Fertility Toxicological Studies
Ms. I. Sai Reddemma.
Department of Pharmacology
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
Similar to An Overview on Anti-epileptic Drugs (20)
The document describes the development of a new magnetic solid phase extraction (MSPE) adsorbent called polyDOPA@Ag-MNPs for the analysis of trace beta-blockers in biological samples. PolyDOPA@Ag-MNPs were synthesized by reducing silver ions on the surface of magnetic nanoparticles coated with poly(3,4-dihydroxyphenylalanine). The adsorbent was able to isolate beta-blockers from sample matrices using a magnetic field. Optimization of the MSPE method identified pH 7, 2 minutes adsorption time, 4 mg polyDOPA@Ag-MNPs, methanol containing 1% acetic acid as the eluent, 2 minutes elution
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Anti-Universe And Emergent Gravity and the Dark UniverseSérgio Sacani
Recent theoretical progress indicates that spacetime and gravity emerge together from the entanglement structure of an underlying microscopic theory. These ideas are best understood in Anti-de Sitter space, where they rely on the area law for entanglement entropy. The extension to de Sitter space requires taking into account the entropy and temperature associated with the cosmological horizon. Using insights from string theory, black hole physics and quantum information theory we argue that the positive dark energy leads to a thermal volume law contribution to the entropy that overtakes the area law precisely at the cosmological horizon. Due to the competition between area and volume law entanglement the microscopic de Sitter states do not thermalise at sub-Hubble scales: they exhibit memory effects in the form of an entropy displacement caused by matter. The emergent laws of gravity contain an additional ‘dark’ gravitational force describing the ‘elastic’ response due to the entropy displacement. We derive an estimate of the strength of this extra force in terms of the baryonic mass, Newton’s constant and the Hubble acceleration scale a0 = cH0, and provide evidence for the fact that this additional ‘dark gravity force’ explains the observed phenomena in galaxies and clusters currently attributed to dark matter.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
Microbial interaction
Microorganisms interacts with each other and can be physically associated with another organisms in a variety of ways.
One organism can be located on the surface of another organism as an ectobiont or located within another organism as endobiont.
Microbial interaction may be positive such as mutualism, proto-cooperation, commensalism or may be negative such as parasitism, predation or competition
Types of microbial interaction
Positive interaction: mutualism, proto-cooperation, commensalism
Negative interaction: Ammensalism (antagonism), parasitism, predation, competition
I. Mutualism:
It is defined as the relationship in which each organism in interaction gets benefits from association. It is an obligatory relationship in which mutualist and host are metabolically dependent on each other.
Mutualistic relationship is very specific where one member of association cannot be replaced by another species.
Mutualism require close physical contact between interacting organisms.
Relationship of mutualism allows organisms to exist in habitat that could not occupied by either species alone.
Mutualistic relationship between organisms allows them to act as a single organism.
Examples of mutualism:
i. Lichens:
Lichens are excellent example of mutualism.
They are the association of specific fungi and certain genus of algae. In lichen, fungal partner is called mycobiont and algal partner is called
II. Syntrophism:
It is an association in which the growth of one organism either depends on or improved by the substrate provided by another organism.
In syntrophism both organism in association gets benefits.
Compound A
Utilized by population 1
Compound B
Utilized by population 2
Compound C
utilized by both Population 1+2
Products
In this theoretical example of syntrophism, population 1 is able to utilize and metabolize compound A, forming compound B but cannot metabolize beyond compound B without co-operation of population 2. Population 2is unable to utilize compound A but it can metabolize compound B forming compound C. Then both population 1 and 2 are able to carry out metabolic reaction which leads to formation of end product that neither population could produce alone.
Examples of syntrophism:
i. Methanogenic ecosystem in sludge digester
Methane produced by methanogenic bacteria depends upon interspecies hydrogen transfer by other fermentative bacteria.
Anaerobic fermentative bacteria generate CO2 and H2 utilizing carbohydrates which is then utilized by methanogenic bacteria (Methanobacter) to produce methane.
ii. Lactobacillus arobinosus and Enterococcus faecalis:
In the minimal media, Lactobacillus arobinosus and Enterococcus faecalis are able to grow together but not alone.
The synergistic relationship between E. faecalis and L. arobinosus occurs in which E. faecalis require folic acid
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.
HUMAN EYE By-R.M Class 10 phy best digital notes.pdf
An Overview on Anti-epileptic Drugs
1. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 1
A seminar as a part of curricular requirement
for I year M. Pharm I semester
Presented by
A. Harsha Vardan Naidu (20L81S0107)
M. Pharmacy
Department of Pharmacology
Under the guidance of
Mr. A. Sudheer kumar, M. Pharm.
Associate Professor, Department of Pharmacology.
2. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 2
• Introduction to Epilepsy
• Types of Seizures
• Classification
• Mechanism of Action
• Pharmacokinetics
• Uses
• Adverse Effects
• Contraindications
• New Drugs
• References
Contents
3. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 3
• Convulsion is a condition in which muscles contract and relax quickly
and cause uncontrolled shaking of the body.
• Seizure is a change in electrical activity between neurons that causes
temporary abnormalities in muscle tone or movements (stiffness,
twitching), behaviours, sensations or states of awareness.
• Epilepsy is a neurological disorder in which brain activity becomes
abnormal, causing seizures or periods of unusual behaviour, sensations,
and sometimes loss of awareness.
• A seizure is a single occurrence, whereas epilepsy is a neurological
condition characterized by two or more unprovoked seizures.
Introduction
4. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 4
• Brain conditions including stroke or a tumour
• Genetical problem
• Head trauma, from a vehicle accident
• Drug abuse or alcohol misuse
• Infectious diseases like viral encephalitis
• Lack of oxygen during birth
• Prenatal injury- brain damage that occurs before child birth
• COVID-19 infection
• Blood vessel malformations
Causes of Epilepsy:
5. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 5
6. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 6
Stages of seizures
7. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 7
• Partial seizures - Simple partial seizure
- Complex partial seizure
- Partial with secondarily generalised seizure
• Generalized seizures - Tonic clonic/ grandmal seizure
- Clonic seizure
- Tonic seizure
- Atonic seizure
- Myoclonic seizure
- Absence/ Petit mal seizure
• Non epileptic seizure- not related to epilepsy, occurs due to diabetes/ high fever.
• Status epilepticus- condition where seizure lasts for more than 5 mins.
Types of seizures
8. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 8
9. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 9
Managing seizures
11. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 11
Conduction of nerve impulse
12. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 12
Mechanism of action
13. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 13
Phenytoin
• First line drug for partial seizures.
• Inhibits Na+ channels.
• Prodrug- Fosphenytoin for IM/IV administration. High plasma
protein binding.
• Adverse effects: CNS sedation ( drowsiness, ataxia, confusion,
insomnia, nystagmus), gum hyperplasia, hirsutism.
Carbamazepine
• First line drug for partial seizures.
• Inhibits Na+ channels.
• Adverse effects- CNS sedation, agranulocytosis and aplastic anaemia
in elderly patients, leukopenia.
14. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 14
Phenobarbital
• Used for partial seizures, effective in neonates.
• Second line drug in adults due to severe CNS sedation.
• Allosteric modulator of GABA-A receptor (increase open time).
• Adverse effects- CNS sedation but produces excitation in some
patients. Skin rashes if allergic. Tolerance and dependence may be
possible.
Primidone
• Used for partial seizures.
• Allosteric modulator of GABA-A receptor (increase open time).
• Not highly bound to plasma.
• Adverse effects- CNS sedation.
15. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 15
Benzodiazepines
• Eg- Diazepam, Clonazepam.
• Used to treat status epilepticus.
• Allosteric modulators of GABA-A receptor- increase frequency.
• Adverse effects- CNS sedation, paradoxical hyper excitability in
children, tolerance and dependence.
Valproate
• Used for partial seizures, first line drug for generalized seizures.
• Enhance GABA transmission, block Na+ channels, activates K+
channels.
• Adverse effects- CNS depression, anorexia, nausea, vomiting, hair
loss, weight gain, may cause birth defects.
16. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 16
Ethosuximide
• Used for absence seizures.
• Blocks T-type Ca++ currents in thalamus.
• Adverese effects- gastric distress, pain, nausea, vomiting.
• Less CNS side effects than other anti-epileptic drugs, transient
fatigue, dizziness, headache.
Oxcarbamazepine
• Approved for add-on therapy, monotherapy for partial seizures, that
are refractory to other antiepileptic drugs.
• Activity dependent blockade of Na+ channels, also open K+
channels.
• Similar to carbamazepine, it causes CNS sedation, but may be less
toxic.
17. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 17
Gabapentin
• Add-on therapy for partial seizures.
• Also effective as monotherapy.
• Interfere with GABA uptake.
• Adverse effects- less CNS sedative than other classic anti-epileptic
drugs.
Lamotrigine
• Add-on therapy and monotherapy for refractive partial seizures.
• Effective against generalized seizures.
• Inhibition of Na+ channels, inhibition of glutamate release, may
inhibit Ca++ channels.
• Less CNS sedative than other anti-epileptic drugs, dermatitis.
18. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 18
Tiagabine
• Add- on therapy for partial seizures.
• Interferes with GABA reuptake.
• CNS sedative
• Minimal drug interaction.
Zonisamide
• Add- on therapy for partial and generalized seizures.
• Blocks Na+ channels and T- type Ca++ channels.
• Causes CNS sedation.
19. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 19
Felbamate
• Third-line drug for refractory partial seizures.
• Frequency dependent- inhibition of Na+ channels, modulation of
NMDA receptors.
• Aplastic anaemia and severe hepatits reduces its use.
Levetiracitam
• Add- on therapy for partial seizures.
• Binds to synaptical vessicle protein SV2A, may regulate
neurotransmitter release.
• Causes CNS ddepression.
20. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 20
• Good absorption from gut, with a bioavailability of 80- 100%.
• They show minimal plasma protein binding( except phenytoin,
valproic acid).
• Half life is usually 12- 24 hours and it increases upto 60 hours
when plasma concentration of drug increases.
• Metabolised in liver by non-CYP450 isoenzymes.
• Enzyme inducers- Phenytoin, Phenobarbital.
• Enzyme inhibitors- Valproate, Topiramate.
• Primarily cleared renally.
Pharmacokinetic profile
21. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 21
• Used to treat partial, generalized and mixed seizures.
• Used to treat Status epilepticus
• Used as prophylaxis in case of tumours in brain.
• Manic depressive illness and acute mania
• Phenytoin is a group 1B anti-arrhythmic agent.
• Several drugs, especially carbamazepine and lamotrigine, are
useful for bipolar disorder.
• Many drugs are useful in migraine, e.g., phenytoin, gabapentin,
topiramate.
Uses of Antiepileptic Drugs
22. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 22
• Hypersensitivity reactions like rashes, photosensitivity, hepatitis
• Vomiting, diarrhoea, weight loss, tremors
• At high plasma levels- ataxia, vertigo, nystagmus, drowsiness
• Gum hypertrophy
• Aplastic anaemia
• Foetal hydantoin syndrome
• Osteoporosis
• Teratogenesis
• Neuropathy, coma
• Epigastric pain, hypotension, arrythmias
Adverse effects
23. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 23
Contraindications
• Cardiac patients
• Pregnant women
• Patients with livers disorder
• People with lung infections etc
Latest discovery
• Levitiracitam
• Brivaracetam
• Cannabidiol
• Stiripentol
24. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 24
1. Padmaja Udaykumar. Pharmacology for Dental and Allied Health
Sciences. 2017; 4th edition.
2. Tripathi, K. D. Essentials of Medical Pharmacology. 2013. JP
Medical Ltd.
3. Christopher Melinosky. Epilepsy drugs used to treat seizures.
WebMD. 2020.
4. Marketa Mavanova. Pharmacokinetic characteristics of
antiepileptic drugs. NCBI. 2016; 6(1): 8-20.
References
25. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 25
THANK YOU